← All candidates
5 insider filings on record.
16 filings on record.
ASMBASSEMBLY BIOSCIENCES, INC.
NasdaqGS · Healthcare · $606.75M
$29.80
-2.17% · Sep 11
5 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$606.75M
Float
9.2M
45% public
Short % float
Pro
Price / profit
24.0
Price / future profit
—
Price / sales
8.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Gilead Sciences, Inc.
Bought 2,295,920 sh on Aug 8 — held direct, 51% of their stake.
0 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
Context
Wall St
$48.75 avg target
+63.6% vs today · 4 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
The file stays open
16 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice